Zhifa Wen

717 total citations
24 papers, 550 citations indexed

About

Zhifa Wen is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Zhifa Wen has authored 24 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Zhifa Wen's work include Immunotherapy and Immune Responses (10 papers), Autophagy in Disease and Therapy (6 papers) and CAR-T cell therapy research (6 papers). Zhifa Wen is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Autophagy in Disease and Therapy (6 papers) and CAR-T cell therapy research (6 papers). Zhifa Wen collaborates with scholars based in China, United States and Bangladesh. Zhifa Wen's co-authors include Hong‐Ming Hu, Lixin Wang, Ning Pan, Fang Huang, Yongqiang Chen, Heng Dong, Rong Gao, Meng Zhou, Yongbin Mou and Jie Ma and has published in prestigious journals such as Advanced Functional Materials, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Zhifa Wen

22 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhifa Wen China 14 316 255 137 113 87 24 550
Nicole Rufo Belgium 9 309 1.0× 188 0.7× 233 1.7× 115 1.0× 28 0.3× 10 615
Ann‐Charlotte Björklund Sweden 7 438 1.4× 268 1.1× 252 1.8× 113 1.0× 51 0.6× 12 791
Jenny Sprooten Belgium 10 381 1.2× 248 1.0× 317 2.3× 66 0.6× 88 1.0× 12 649
Wenshan Zhao China 15 109 0.3× 219 0.9× 101 0.7× 45 0.4× 75 0.9× 27 495
Arati Limaye United States 6 143 0.5× 178 0.7× 128 0.9× 109 1.0× 36 0.4× 10 511
Donye Dominguez United States 12 457 1.4× 296 1.2× 178 1.3× 64 0.6× 64 0.7× 15 693
Priyamvada Jayaprakash United States 10 296 0.9× 295 1.2× 228 1.7× 90 0.8× 224 2.6× 14 679
Dorota D. Klysz United States 5 381 1.2× 302 1.2× 359 2.6× 179 1.6× 146 1.7× 5 831
Stéphanie Cornen France 6 655 2.1× 333 1.3× 419 3.1× 186 1.6× 102 1.2× 10 1000
Thierry Marysael Belgium 4 360 1.1× 207 0.8× 220 1.6× 226 2.0× 44 0.5× 5 719

Countries citing papers authored by Zhifa Wen

Since Specialization
Citations

This map shows the geographic impact of Zhifa Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifa Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifa Wen more than expected).

Fields of papers citing papers by Zhifa Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifa Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifa Wen. The network helps show where Zhifa Wen may publish in the future.

Co-authorship network of co-authors of Zhifa Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifa Wen. A scholar is included among the top collaborators of Zhifa Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifa Wen. Zhifa Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Qiang, Meng Dang, Junwu Tao, et al.. (2024). Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine (Adv. Funct. Mater. 26/2024). Advanced Functional Materials. 34(26). 1 indexed citations
3.
Li, Qiang, Meng Dang, Junwu Tao, et al.. (2024). Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine. Advanced Functional Materials. 34(26). 11 indexed citations
5.
Li, Xiaoye, Zhuo Dai, Qiang Li, et al.. (2023). Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy. Journal of Nanobiotechnology. 21(1). 45 indexed citations
6.
Cheng, Feng, Weimin Fan, Ling Gui, et al.. (2023). Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer. Analytical and Bioanalytical Chemistry. 415(10). 1841–1854. 9 indexed citations
7.
Li, Qiang, et al.. (2022). Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma. Frontiers in Cell and Developmental Biology. 10. 941750–941750. 28 indexed citations
8.
Sun, Xiaotong, Chunguang Yan, Shiya Zheng, et al.. (2022). Tumor cell–released LC3‐positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation. Cancer Science. 113(10). 3405–3416. 16 indexed citations
9.
Huang, Fang, Ning Pan, Jinjin Zhao, et al.. (2021). Effects of Combinatorial Ubiquitinated Protein-Based Nanovaccine and STING Agonist in Mice With Drug-Resistant and Metastatic Breast Cancer. Frontiers in Immunology. 12. 707298–707298. 12 indexed citations
10.
Huang, Fang, Jinjin Zhao, Zhifa Wen, et al.. (2020). <p>Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells</p>. International Journal of Nanomedicine. Volume 15. 1021–1035. 13 indexed citations
11.
Cheng, Feng, et al.. (2020). A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer. Life Sciences. 260. 118489–118489. 22 indexed citations
12.
Zhang, Tianyu, et al.. (2020). Tumor cell-derived autophagosomes (DRibbles)-activated B cells induce specific naïve CD8+ T cell response and exhibit antitumor effect. Cancer Immunology Immunotherapy. 70(2). 463–474. 9 indexed citations
13.
Chen, Yongqiang, Pengcheng Li, Ning Pan, et al.. (2019). Tumor-released autophagosomes induces CD4+ T cell-mediated immunosuppression via a TLR2–IL-6 cascade. Journal for ImmunoTherapy of Cancer. 7(1). 178–178. 46 indexed citations
15.
Zhang, Yue, Ning Pan, Meng Zhou, et al.. (2019). Hypoxia enhances IL-10-producing B cell generation through upregulating high-mobility group B1 on tumor cell-released autophagosomes. Immunology Letters. 216. 36–42. 16 indexed citations
16.
Chen, Yongqiang, Pengcheng Li, Ning Pan, et al.. (2019). Tumor-released autophagosomes induces CD4. 7(1). 178. 3 indexed citations
17.
Wen, Zhifa, Hongxiang Liu, Rong Gao, et al.. (2018). Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. Journal for ImmunoTherapy of Cancer. 6(1). 151–151. 133 indexed citations
18.
Dong, Heng, Zhifa Wen, Lin Chen, et al.. (2018). Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells. International Journal of Nanomedicine. Volume 13. 3353–3365. 50 indexed citations
19.
Zhou, Meng, Zhifa Wen, Feng Cheng, et al.. (2016). Tumor-released autophagosomes induce IL-10-producing B cells with suppressive activity on T lymphocytes via TLR2-MyD88-NF-κB signal pathway. OncoImmunology. 5(7). e1180485–e1180485. 53 indexed citations
20.
Zhou, Meng, Weixia Li, Zhifa Wen, et al.. (2014). Macrophages enhance tumor-derived autophagosomes (DRibbles)-induced B cells activation by TLR4/MyD88 and CD40/CD40L. Experimental Cell Research. 331(2). 320–330. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026